Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study

Vestibular migraine is considered the most common cause of recurrent vertigo for which specific treatments are missing. Monoclonal antibodies against calcitonin gene-related peptide,, are effective in preventing migraine. Since CGRP is also detected in human cochlear and vestibular organs it may als...

Full description

Saved in:

Bibliographic Details
Published in:	Cephalalgia Vol. 43; no. 4; p. 3331024231161809
Main Authors:	Russo, Cinzia Valeria, Saccà, Francesco, Braca, Simone, Sansone, Mattia, Miele, Angelo, Stornaiuolo, Antonio, De Simone, Roberto
Format:	Journal Article
Language:	English
Published:	England 01.04.2023
Subjects:	Antibodies, Monoclonal - therapeutic use Calcitonin Gene-Related Peptide Cohort Studies Dizziness - drug therapy Headache - drug therapy Humans Migraine Disorders - prevention & control Prospective Studies Quality of Life Vertigo - chemically induced Vertigo - drug therapy anti-calcitonin gene-related peptide dizziness vestibular migraine monoclonal antibody vertigo Migraine
ISSN:	1468-2982, 1468-2982
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!